Related Experiment Videos
Methylprednisolone acetate does not cause inflammatory changes in the epidural space.
R S Cicala1, R Turner, E Moran
1Department of Anesthesiology, University of Tennessee, Memphis 38163.
Anesthesiology
|March 1, 1990
Summary
Epidural injections of methylprednisolone acetate showed no adverse effects on meningeal membranes or nervous tissue in rabbits. This pilot study suggests epidural methylprednisolone acetate is safe for epidural space injections.
Area of Science:
- Neurology
- Pharmacology
- Histology
Background:
- Limited research exists on the potential adverse effects of epidural depot corticosteroid injections on neural tissues.
- Understanding these effects is crucial for patient safety during epidural steroid therapy.
Purpose of the Study:
- To evaluate the safety of epidural methylprednisolone acetate by examining its effects on meningeal membranes and nervous tissue.
- To assess potential inflammatory responses following epidural corticosteroid administration.
Main Methods:
- Thirty-six rabbits received epidural injections: lactated Ringer's solution (control), 1% lidocaine with methylprednisolone acetate (study), or normal saline with talc (positive control).
- Spinal cord and meningeal tissues were examined via light microscopy at 4 and 10 days post-injection.
Main Results:
- No white cell infiltrates or fibroblastic activity were observed in animals receiving lactated Ringer's or methylprednisolone acetate.
- Animals treated with talc showed significant tissue macrophage infiltration.
- No meningeal membrane or nerve root thickening occurred in any group.
Conclusions:
- The absence of inflammatory changes and meningeal thickening supports the safety of methylprednisolone acetate for epidural injections.
- This pilot study provides preliminary evidence for the safety profile of epidural methylprednisolone acetate.